REVIVE AT CYCLE MEETING

REVIVE AT CYCLE MEETING

1st Grade

10 Qs

quiz-placeholder

Similar activities

Askep Anak 1

Askep Anak 1

1st - 3rd Grade

8 Qs

Evaluasi Panum transfusi darah

Evaluasi Panum transfusi darah

1st Grade

10 Qs

Messefest

Messefest

1st - 5th Grade

12 Qs

dolicox forte

dolicox forte

1st - 2nd Grade

10 Qs

IPD-Rheumatologi

IPD-Rheumatologi

KG - Professional Development

10 Qs

ALIMENTACIÓN ESCOLAR Y ADOLESCENTE

ALIMENTACIÓN ESCOLAR Y ADOLESCENTE

1st - 2nd Grade

11 Qs

IPD-Nefrologi

IPD-Nefrologi

KG - Professional Development

10 Qs

OTITIS

OTITIS

1st - 3rd Grade

10 Qs

REVIVE AT CYCLE MEETING

REVIVE AT CYCLE MEETING

Assessment

Quiz

Professional Development

1st Grade

Medium

Created by

Sayalee Kesarkar

Used 2+ times

FREE Resource

10 questions

Show all answers

1.

MULTIPLE CHOICE QUESTION

45 sec • 1 pt

With me 2 weeks of treatment can give the patients 10 weeks of relief from abdominal pain and diarrhoea. Who am I?

Acogut

Rcifax

Cizaspa SR

Pegalup

2.

MULTIPLE CHOICE QUESTION

45 sec • 1 pt

Acogut 300 ER "increases accomodation and improves _________".

Dyspepsia

Hyperacidity

Gut motiliy

Quality of life

3.

MULTIPLE CHOICE QUESTION

45 sec • 1 pt

Hyperuricemia leads to painful gout arthritis. So, aim is to reduce sUA levels to __

< 10 mg/dl

> 8mg/dl

< 6 mg/dl

< 8-9 mg/dl

4.

MULTIPLE CHOICE QUESTION

45 sec • 1 pt

The recommended dosage of UDCA in Cholestatic Liver disease is _____

13-15 mg/kg body weight

10-12 mg/kg body weight

6-10 mg/kg body weight

4-5 mg/kg body weight

5.

MULTIPLE CHOICE QUESTION

45 sec • 1 pt

Acogut gives signifcant to complete relief from meal related _____ symptoms.

Epigastric pain syndrome

Dyspepsia

Irritable bowel syndrome

Post prandial distress syndrome

6.

MULTIPLE CHOICE QUESTION

45 sec • 1 pt

Dr Ghosh shared that his patient is suffering from Cholelithiasis and is obese weighing around 105 kgs. Which of the following would be the right prescription for his patient?

Ulyses 300 BID

Acogut 300 OD

Rcifax 400 TID

Ulyses 450 SR TID

7.

MULTIPLE CHOICE QUESTION

45 sec • 1 pt

"The percentage of patients requiring treatment for gout flares declined to zero after 5 years of treatment with Febuxostat".

This concluding statement has been taken from which trial?

Confirm Trial

Focus Trial

Freed Trial

Journal of Clinical Rheumtology

Create a free account and access millions of resources

Create resources

Host any resource

Get auto-graded reports

Google

Continue with Google

Email

Continue with Email

Classlink

Continue with Classlink

Clever

Continue with Clever

or continue with

Microsoft

Microsoft

Apple

Apple

Others

Others

By signing up, you agree to our Terms of Service & Privacy Policy

Already have an account?